FDA received another large bolus of generic drug applications in March and industry now is on pace to equal the annual record for submissions received set in fiscal year 2014.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?